Annual Current Liabilities
$92.26 M
+$22.79 M+32.79%
December 31, 2024
Summary
- As of March 13, 2025, KPTI annual total current liabilities is $92.26 million, with the most recent change of +$22.79 million (+32.79%) on December 31, 2024.
- During the last 3 years, KPTI annual current liabilities has risen by +$18.55 million (+25.16%).
- KPTI annual current liabilities is now at all-time high.
Performance
KPTI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$92.26 M
+$30.77 M+50.04%
December 31, 2024
Summary
- As of March 13, 2025, KPTI quarterly total current liabilities is $92.26 million, with the most recent change of +$30.77 million (+50.04%) on December 31, 2024.
- Over the past year, KPTI quarterly current liabilities has stayed the same.
- KPTI quarterly current liabilities is now at all-time high.
Performance
KPTI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
KPTI Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.8% | 0.0% |
| 3 y3 years | +25.2% | 0.0% |
| 5 y5 years | +99.1% | 0.0% |
KPTI Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.0% | at high | +60.1% |
| 5 y | 5-year | at high | +99.1% | at high | +99.1% |
| alltime | all time | at high | +4680.5% | at high | +4680.5% |
Karyopharm Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $92.26 M(+32.8%) | $92.26 M(+50.0%) |
| Sep 2024 | - | $61.49 M(+6.7%) |
| Jun 2024 | - | $57.62 M(-11.8%) |
| Mar 2024 | - | $65.34 M(-6.0%) |
| Dec 2023 | $69.48 M(+5.4%) | $69.48 M(+11.9%) |
| Sep 2023 | - | $62.08 M(+5.3%) |
| Jun 2023 | - | $58.93 M(-4.3%) |
| Mar 2023 | - | $61.55 M(-6.6%) |
| Dec 2022 | $65.91 M(-10.6%) | $65.91 M(+6.7%) |
| Sep 2022 | - | $61.76 M(-1.2%) |
| Jun 2022 | - | $62.54 M(-5.7%) |
| Mar 2022 | - | $66.34 M(-10.0%) |
| Dec 2021 | $73.72 M(+22.4%) | $73.72 M(+7.0%) |
| Sep 2021 | - | $68.87 M(+18.5%) |
| Jun 2021 | - | $58.12 M(-6.3%) |
| Mar 2021 | - | $62.01 M(+3.0%) |
| Dec 2020 | $60.20 M(+29.9%) | $60.20 M(+14.4%) |
| Sep 2020 | - | $52.63 M(+4.1%) |
| Jun 2020 | - | $50.57 M(+1.8%) |
| Mar 2020 | - | $49.70 M(+7.2%) |
| Dec 2019 | $46.35 M(-1.2%) | $46.35 M(+18.2%) |
| Sep 2019 | - | $39.20 M(+21.8%) |
| Jun 2019 | - | $32.17 M(-26.6%) |
| Mar 2019 | - | $43.86 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $46.90 M(-5.2%) | $46.90 M(+12.8%) |
| Sep 2018 | - | $41.57 M(+13.7%) |
| Jun 2018 | - | $36.54 M(-21.8%) |
| Mar 2018 | - | $46.73 M(-5.5%) |
| Dec 2017 | $49.47 M(+200.2%) | $49.47 M(+133.8%) |
| Sep 2017 | - | $21.16 M(+20.7%) |
| Jun 2017 | - | $17.52 M(+13.2%) |
| Mar 2017 | - | $15.48 M(-6.0%) |
| Dec 2016 | $16.48 M(+8.9%) | $16.48 M(+10.2%) |
| Sep 2016 | - | $14.95 M(-3.7%) |
| Jun 2016 | - | $15.52 M(+17.4%) |
| Mar 2016 | - | $13.22 M(-12.6%) |
| Dec 2015 | $15.13 M(+23.0%) | $15.13 M(+4.8%) |
| Sep 2015 | - | $14.44 M(+2.4%) |
| Jun 2015 | - | $14.10 M(-4.1%) |
| Mar 2015 | - | $14.70 M(+19.5%) |
| Dec 2014 | $12.30 M(+273.7%) | $12.30 M(+97.3%) |
| Sep 2014 | - | $6.23 M(+10.4%) |
| Jun 2014 | - | $5.65 M(+12.6%) |
| Mar 2014 | - | $5.01 M(+52.3%) |
| Dec 2013 | $3.29 M(+70.6%) | $3.29 M(-17.6%) |
| Sep 2013 | - | $4.00 M(+57.3%) |
| Jun 2013 | - | $2.54 M(+31.7%) |
| Dec 2012 | $1.93 M(-8.8%) | $1.93 M |
| Dec 2011 | $2.12 M | - |
FAQ
- What is Karyopharm Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual current liabilities year-on-year change?
- What is Karyopharm Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly current liabilities year-on-year change?
What is Karyopharm Therapeutics annual total current liabilities?
The current annual current liabilities of KPTI is $92.26 M
What is the all time high annual current liabilities for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual total current liabilities is $92.26 M
What is Karyopharm Therapeutics annual current liabilities year-on-year change?
Over the past year, KPTI annual total current liabilities has changed by +$22.79 M (+32.79%)
What is Karyopharm Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of KPTI is $92.26 M
What is the all time high quarterly current liabilities for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly total current liabilities is $92.26 M
What is Karyopharm Therapeutics quarterly current liabilities year-on-year change?
Over the past year, KPTI quarterly total current liabilities has changed by $0.00 (0.00%)